Diabetes and Obesity ELISA Kits Products & Reviews

Immunoassay for quantitative determination of rat C-peptide in serum, plasma or cell culture medium. Mercodia Diabetes Antigen Control – Rat & Mouse (10-1220-01) is designed to be used as a three-level control for the Mercodia Rat C-peptide ELISA.

A dilution buffer that can be used in several Mercodia ELISAs.

Mercodia Bovine Insulin ELISA is a high-quality, species-optimized enzyme immunoassay for the quantification of bovine insulin in serum or plasma. Mercodia Animal Insulin Control (10-1221-01) is designed to be used as a three-level control for Porcine Insulin ELISA.

Mercodia Equine Insulin ELISA is a species-optimized, high-quality enzyme immunoassay for the quantification of equine insulin in serum or plasma. Mercodia Animal Insulin Control (10-1221-01) is designed to be used as a three-level control for Porcine Insulin ELISA.

Control set containing rat and mouse insulin and rat C-peptide to be used in the rat and mouse insulin kits as well as in Rat C-peptide ELISA. Perform the Mercodia ELISA according to the "Directions for Use", handling Diabetes Antigen Control Rat&Mouse (Low, Medium, High) as samples. The controls contain rat insulin, mouse insulin, and rat C-peptide

ELISA kit for quantitative determination of rat and mouse proinsulin in serum, plasma, cell culture media or tissue homogenate.

Mercodia Ultrasensitive Rat Insulin ELISA provides a method for the quantitative determination of low levels of insulin in rat samples. Mercodia Diabetes Antigen Control – Rat & Mouse (10-1220-01) is designed to be used as a three-level control for the Mercodia Ultrasensitive Rat Insulin ELISA.

An assay for the quantitative determination of porcine C-peptide in serum, plasma and cell culture medium. The assay may be used for post-transplant assessment of porcine islet xenograft function in human, macaque, rat or mouse. Enables distinguishing endogenously produced C-peptide for pharmacodynamic and/or pharmacokinetic studies during exogenous insulin administration.

Mercodia Glucagon ELISA – 10 µL is a highly specific and sensitive immunoassay for measuring glucagon in serum, EDTA plasma, and cell culture media samples from rat, mouse, and non-human primates. A revolutionizing ELISA for sensitive and specific determination of glucagon in rat, mouse, and non-human primate (NHP) samples. A research tool advancement that allows science to take the next step.

Mercodia GLP-1 (9-36) Amide Control – Low, Medium, High is a three-level control for Mercodia Total GLP-1 ELISA (10-1278-01). The Mercodia GLP-1 (9-36) Amide Control – Low, Medium, High contains synthetic GLP-1 (9-36) amide in stabilized serum. The content of each vial is lyophilized, containing 500 µL after reconstitution.

For quantitative detection of human Adiponectin in cell culture supernates, serum, plasma(heparin, EDTA), tissue homogenates and urine.

Enzyme Immunoassay for the quantitative determination of Insulin Lispro in serum, plasma and cell culture supernatant

ELISA for the quantitative determination of Insulin Glargine in serum and plasma samples.

ELISA for the quantitative determination of Insulin Aspart in serum and plasma samples.

ELISA for the quantitative determination of Exenatide in human serum and plasma.

ELISA for the quantitative determination of Liraglutide (VICTOZA™) in serum and plasma.

ELISA for the quantitative determination of Semaglutide in serum and plasma.

OXM causes weight loss via suppression of food intake and increase in energy expenditure. OXM administration was also reported to increase heart-rate in mice. Besides regulating glucose homeostasis in monogastric animals, OXM also increases the concentration of insulin and glucose in plasma of Holstein cattle under normal physiological conditions. It has been shown that Type 2 diabetes patients have lower levels of OXM and lev…

The ratio of Total to Intact IGFBP-4 concentration measured in individual subjects over time will help normalizes the IGFBP-4 variability between subjects and also increase the detection rate of increased PAPP-A activity in myocardial infarction subjects.

The Glucagon Enzyme Linked Immunosorbent Assay (ELISA) kit provides materials for the quantitative measurement of Glucagon in human plasma and other biological fluids.

IGFBP-3 exhibits intrinsic growth-regulating effects that are not yet fully understood, but have evoked interest with regards to a possible role of IGFBP-3 as a prognostic tumor marker. Low IGFBP-3 and IGF-I levels are observed in GH deficiency or GH resistance, also epidemiologic studies suggest that low IGFBP-3 is associated with greater risk of aggressive, metastatic prostate cancers. 

Several studies have shown that concentration of PAPP-A in blood of patients with acute coronary syndrome (ACS) is higher than in blood of patients with stable coronary artery disease or control subjects. PAPP-A has been suggested as a marker of cardiovascular diseases associated with coronary artery blood clotting, such as unstable angina and myocardial infarction (MI). 

Follistatin-like 3 (FSTL-3), also known as Follistatin-related Accurate Gene (FLRG) and Follistatin-related protein (FSRP), is a 30-35 kDa secreted glycoprotein. FSTL-3 encodes a novel secreted glycoprotein that is highly homologous to follistatin and binds activins and bone morphogenetic proteins, members of the TGF beta superfamily of growth/differentiation  factors. 

The Mouse Activin B enzyme linked immunuosorbent assay (ELISA) kit provides materials for the quantitative measurement of Activin B in mouse serum and other biological fluids

IGFBP-3 exhibits intrinsic growth-regulating effects that are not yet fully understood, but have evoked interest with regards to a possible role of IGFBP-3 as a prognostic tumor marker. Low IGFBP-3 and IGF-I levels are observed in GH deficiency or GH resistance, also epidemiologic studies suggest that low IGFBP-3 is associated with greater risk of aggressive, metastatic prostate cancers.